1. Zeng, Lijuan, Zeng, Jun, He, Jianfeng, Wu, Huilin, Zhou, Libin. 2024. FCGBP functions as a tumor suppressor gene in head and neck squamous cell carcinoma. In Discover oncology, 15, 704. doi:10.1007/s12672-024-01607-8. https://pubmed.ncbi.nlm.nih.gov/39580769/
2. Kim, Young S, Ho, Samuel B. . Intestinal goblet cells and mucins in health and disease: recent insights and progress. In Current gastroenterology reports, 12, 319-30. doi:10.1007/s11894-010-0131-2. https://pubmed.ncbi.nlm.nih.gov/20703838/
3. Wang, Yating, Liu, Yan, Liu, Huiqiao, Fu, Jiangtao, Wang, Xiaofei. 2017. FcGBP was upregulated by HPV infection and correlated to longer survival time of HNSCC patients. In Oncotarget, 8, 86503-86514. doi:10.18632/oncotarget.21220. https://pubmed.ncbi.nlm.nih.gov/29156811/
4. Wang, Kai, Guan, Chenan, Shang, Xianwen, Xia, Liang, Chai, Zeying. 2021. A bioinformatic analysis: the overexpression and clinical significance of FCGBP in ovarian cancer. In Aging, 13, 7416-7429. doi:10.18632/aging.202601. https://pubmed.ncbi.nlm.nih.gov/33686968/
5. Yan, Tengfeng, Tian, Daofeng, Chen, Junhui, Cai, Linzhi, Chen, Qianxue. 2022. FCGBP Is a Prognostic Biomarker and Associated With Immune Infiltration in Glioma. In Frontiers in oncology, 11, 769033. doi:10.3389/fonc.2021.769033. https://pubmed.ncbi.nlm.nih.gov/35047393/
6. Shen, Ting, Zhang, Jianying, Wang, Yali, Liu, Binjie. 2022. FCGBP Is a Promising Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Oral Squamous Cell Carcinoma. In Journal of immunology research, 2022, 8443392. doi:10.1155/2022/8443392. https://pubmed.ncbi.nlm.nih.gov/35733916/
7. Ding, Qin, Lin, Fengjie, Huang, Zongwei, Liu, Hui, Qiu, Sufang. 2024. Non-coding RNA-related FCGBP downregulation in head and neck squamous cell carcinoma: a novel biomarker for predicting paclitaxel resistance and immunosuppressive microenvironment. In Scientific reports, 14, 4426. doi:10.1038/s41598-024-55210-6. https://pubmed.ncbi.nlm.nih.gov/38396056/
8. Lin, Yu-Hsuan, Yang, Yi-Fang, Shiue, Yow-Ling. 2022. Multi-Omics Analyses to Identify FCGBP as a Potential Predictor in Head and Neck Squamous Cell Carcinoma. In Diagnostics (Basel, Switzerland), 12, . doi:10.3390/diagnostics12051178. https://pubmed.ncbi.nlm.nih.gov/35626334/
智鼠故事 
